| Trial ID: | L0284 |
| Source ID: | NCT01571063
|
| Associated Drug: |
Vitamin D
|
| Title: |
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Steatohepatitis (NASH)
|
| Interventions: |
Drug: Vitamin D3|Drug: Placebo
|
| Outcome Measures: |
Change from Baseline in serum alanine aminotransferase levels at week 48
|
| Sponsor/Collaborators: |
University of Zurich
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
22
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
January 2013
|
| Completion Date: |
May 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
October 25, 2016
|
| Locations: |
University Hospital Zurich, Gastroenterology and Hepatology, Zurich, ZH, Switzerland|Kantonsspital St. Gallen, St. Gallen, Switzerland
|
| URL: |
https://ClinicalTrials.gov/show/NCT01571063
|
